Clinical Trial Update: SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the optimal antithrombotic strategy for patients undergoing coronary drug-eluting stent implantation; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Joo-Yong Hahn | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED